Financial Daily from THE HINDU group of publications
Friday, Jun 28, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Mergers & Acquisitions


Parke-Davis — Pfizer merger swap ratio set at 9:4

Our Bureau

MUMBAI, June 27

THE boards of directors of Parke-Davis (India) Ltd and Pfizer Ltd today approved the share swap ratio of 9:4 (nine shares of Parke-Davis for every four shares of Pfizer) for the proposed merger of Parke Davis India and Pfizer.

According to a press release, the merger of the two companies will create the fourth largest pharmaceutical company in India with a combined turnover of Rs 701.5 crore based on November 2001 audited results with an estimated market share of 3.74 per cent.

The merger will be effective from December 1, 2001 subject to statutory requirements.

Send this article to Friends by E-Mail

Stories in this Section
Tata Steel geared for price hikes


ASC Enterprises applies for DTH licence
Silverline proposal
Sterlite Industries' assurance to court
WorldCom scandal to hit Indian operations
Whirl called WorldCom
Tata Teleservices to buy 50.83 pc in Hughes Tele
Feelers to IOC on MRPL stake
Parke-Davis — Pfizer merger swap ratio set at 9:4
Ranbaxy in licensing deal with German co
Tata Steel inks pact with TN for titanium dioxide project
Ranbaxy buys Veratide from P&G in Germany
ISO 9001 for Bhima Jewellers
Sodexho getting fat with corporates' voucher-culture
Little progress in Ambani's condition
Naidu visits Breach Candy Hospital


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line